SELP and endometriosis: The treatment with a recombinant P-selectin in a mouse with induced endometriosis resulted in soluble P-selectin treatment markedly reduced the lesion size in the mouse through decreased platelet aggregation and angiogenesis, improved general hyperalgesia, and the reduced extent of macrophages infiltration, resulting in reduced fibrotic tissue content [230].